883 filings
Page 3 of 45
DEFA14A
gx2yi1u3
1 May 23
Additional proxy soliciting materials
8:02am
D
w9ui0vx0vkcqbuxut
31 Mar 23
$25.00 mm in equity / options, sold $25.00 mm, 17 investors
11:30am
8-K
tq9dj
29 Mar 23
Delcath Systems Announces up to $85 Million Financing
9:45pm
8-K
w1tg xjfbc676rt
27 Mar 23
Regulation FD Disclosure
9:09pm
8-K
ny2kjvgbqt ta
27 Mar 23
Delcath Systems Announces up to $85 Million Financing
4:32pm
424B5
07rpwd8hj48e3gfvyhn
27 Feb 23
Prospectus supplement for primary offering
4:58pm
8-K
qf4oh3rvqw7mew
24 Feb 23
Other Events
6:06am
8-K
lu8eeb 9g
14 Feb 23
Delcath Systems Announces New Drug Application Resubmission for HEPZATO Kit
10:58am
8-K
a8fa8k218i5tjkpdqx
23 Jan 23
Other Events
7:01am
EFFECT
rzs3nu23lxbk3fob2q
23 Jan 23
Notice of effectiveness
12:15am
424B3
yvt1rqrvg5thc6m0l9
20 Jan 23
Prospectus supplement
4:38pm
CORRESP
0n186c
18 Jan 23
Correspondence with SEC
12:00am
UPLOAD
mzdos
17 Jan 23
Letter from SEC
12:00am
8-K
yqex5d1ijrz7de
10 Jan 23
Other Events
4:12pm
8-K
u5rkrxo hnkt94005z
3 Jan 23
Regulation FD Disclosure
4:17pm
SC 13D/A
zjh83
21 Dec 22
DELCATH SYSTEMS / Rosalind Advisors ownership change
12:17pm